Expanded Access Use of INCB054329 to Treat a Single Patient With Metastatic Renal Cell Carcinoma

Incyte

Status

Treatments: Drug: INCB054329

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT03896815

I-54329-17-01

Details and patient eligibility

About

Expanded access use of INCB054329 to treat a single patient with metastatic renal cell carcinoma.

Sex

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria